- Mireia Córcoles
- No Comments
- The entity has signed a collaboration agreement with the Parc Taulí Research and Innovation Institute to raise funds through a solidarity wine initiative, and to contribute €25.000 annually for research into minority diseases
Cellers Maset and the Parc Taulí Research and Innovation Institute (I3PT) have signed a collaboration agreement for the creation of the first Pau Massana Scholarship for Rare Diseases.
This scholarship is an initiative of the winery to raise funds and contribute, every year, €25.000 for research into diseases of low or very low prevalence in society.
To achieve this economic figure, the Penedesenc winery puts on sale 2.500 numbered bottles of Cava Solidarity of Cellers Maset. 100% of the collection will go to the creation of the Pau Massana Scholarship.
The collaboration between the two entities was formalized last September 14 with the director of the I3PT, Lluís Blanch, and the manager of the winery, Marc Massana.
The I3PT will open one early next year competitive scholarship addressed to research staff to finance a pulmonary clinical research project of theresearch area of Rare Diseases of the I3PT. The winery has expressed its desire to fund this scholarship annually to continue raising funds for minority disease research projects.
The name of the scholarship is a "small tribute to the youngest son of Josep Massana and Imma Torreño, Pau, who at the beginning of 2000 suffered from a minor lung disease", explains Marc Massana.
As the manager of the winery emphasizes, the cava Solidari Maset's organic brut nature "is a special blend of xarel·lo, macabeo and parellada aged for twelve months in rimes. It stands out for its freshness and its fragrant aromas of ripe white fruit, pastry and citrus on a background of chamomile and raw almond. A light and tasty cava ideal to accompany any get-together or a low-intensity starter”.
You might also like
Investigating Fragile X syndrome in girls and adolescentsInvestigating Fragile X syndrome in girls and adolescents https://www.tauli.cat/institut/wp-content/uploads/2024/02/Plantilla-Imatges-Web-169-22-1200x675.jpg 1080 608 Oriol Capell Oriol Capell https://secure.gravatar.com/avatar/97c9519819f851a011f17a028acac50c?s=96&d=mm&r=g
I3PT, CONNECTA Therapeutics, CRG and IMIM receive 2,7 million from the Ministry of Science and Innovation to start Phase IIa of the drug CTH120 for fragile X syndromeI3PT, CONNECTA Therapeutics, CRG and IMIM receive 2,7 million from the Ministry of Science and Innovation to start Phase IIa of the drug CTH120 for fragile X syndrome https://www.tauli.cat/institut/wp-content/uploads/2024/02/Plantilla-Imatges-Web-169-1200x675.jpg 1080 608 Mireia Córcoles Mireia Córcoles https://www.tauli.cat/institut/wp-content/uploads/2022/11/Tezza-0184-150x150.jpg
The I3PT wins 2 scholarships from the Ministry for a value of more than 700.000 eurosThe I3PT wins 2 scholarships from the Ministry for a value of more than 700.000 euros https://www.tauli.cat/institut/wp-content/uploads/2024/01/ResolucioConvocatories-1200x675.jpg 1080 608 Oriol Capell Oriol Capell https://secure.gravatar.com/avatar/97c9519819f851a011f17a028acac50c?s=96&d=mm&r=g